Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sen. Kerry Dismayed By Lack Of Congressional Action On HIV Vaccines

This article was originally published in The Pink Sheet Daily

Executive Summary

Congress has missed opportunities to offer significant support for HIV vaccine research, Sen. John Kerry (D-Mass.) said at a June 23 Foreign Relations Committee hearing on the topic of HIV vaccines. Both the Senate and the House have passed resolutions this year supporting the acceleration of HIV vaccine research. New estimates from the United Nations program on HIV/AIDS suggest that the developing world will need $15 bil. in 2006 to help reverse the spread of the disease.

You may also be interested in...



National Academies’ Follow-up To Fink Report Calls For New Independent Advisory Body To Assess Biological Threats

The new advisory body would have a mission distinct from that of the recently formed National Science Advisory Board for Biosecurity.

Leavitt Defends Bush’s Flu Pandemic Preparedness Plan To Senate

HHS will subsidize about 25% of states’ antiviral costs, leading senators to question whether preparedness in some states could suffer.

Rep. Castle Looks Ahead To September Stem Cell Clash

The representative remains resolute in the wake of scientific findings that could be used by some to undercut his Stem Cell Research Enhancement Act (HR 810/S 471).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059800

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel